header
Image from OpenLibrary

Circumventing the genetic susceptibility of tamoxifen through pro-drug principle / Nouran Moustafa Hussein Elsawaf ; Supervised Ashraf H. Abadi , Nermin Salah Ahmed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Nouran Moustafa Hussein Elsawaf , 2016Description: 101 Leaves ; 30cmOther title:
  • التحايل على القابلية الوراثية للتاموكسيفين من خلال مبدأ الدواء المساعد [Added title page title]
Subject(s): Dissertation note: Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Chemistry Summary: Selective estrogen receptor modulatory (SERMs) are a class of compounds that can act as estrogen receptor (ER) agonists in some tissues while acting as ER antagonists in others. They represent one of the most important xlasses for the treatment of breast cancer, osteoporosis, ovulatory infertility and cardiovascular disease. Tamoxifen was the first SERM to be used in the treatment of metastatic breast cancer. Tamoxifen has evolved as an agent used in all stages of breast cancer especially ER-positive treast cancer, over the past 30 years
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Status Date due Barcode
Thesis Thesis قاعة الثقاقات الاجنبية - الدور الثالث المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.34.M.Sc.2016.No.C (Browse shelf(Opens below)) Not for loan 01010110072438000

Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Pharmaceutical Chemistry

Selective estrogen receptor modulatory (SERMs) are a class of compounds that can act as estrogen receptor (ER) agonists in some tissues while acting as ER antagonists in others. They represent one of the most important xlasses for the treatment of breast cancer, osteoporosis, ovulatory infertility and cardiovascular disease. Tamoxifen was the first SERM to be used in the treatment of metastatic breast cancer. Tamoxifen has evolved as an agent used in all stages of breast cancer especially ER-positive treast cancer, over the past 30 years

There are no comments on this title.

to post a comment.